Pham Katherine
PharmD, BCPPS. American College of Clinical Pharmacy. Washington, DC (United States).
Pharm Pract (Granada). 2020 Oct-Dec;18(4):2238. doi: 10.18549/PharmPract.2020.4.2238. Epub 2020 Dec 8.
The increasing prevalence of complex, chronic conditions has profound implications on the growing demand and cost of health care. The Center for Medicare and Medicaid Innovation is testing data-driven approaches to care delivery and payment that are drawn from innovative practices of health care providers and other partners in the health care community. The shift from fee-for-service to value-based care and performance-based payment places increased priority on improved outcomes at lower costs. To advance comprehensive medication management, pharmacists need to understand the opportunities in the evolving value-based payment models and align medication optimization with the specific goals and incentives of these models.
复杂慢性病的患病率不断上升,对医疗保健需求的增长和成本产生了深远影响。医疗保险和医疗补助创新中心正在测试基于数据的医疗服务提供和支付方式,这些方式源自医疗服务提供者及医疗保健界其他合作伙伴的创新实践。从按服务收费转向基于价值的医疗和基于绩效的支付,使得以更低成本改善医疗结果的优先级更高。为推进全面药物管理,药剂师需要了解不断演变的基于价值的支付模式中的机遇,并使药物优化与这些模式的具体目标和激励措施保持一致。